Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02255331 · ClinicalTrials.gov registry record

Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity

A clinical trial of Complications; Arthroplasty and Complications; Arthroplasty, Mechanical, sponsored by Hospital for Special Surgery, New York.

Recruiting
Registry status
240
Enrollment target
1
Study location

NCT02255331 is a study of Complications; Arthroplasty and Complications; Arthroplasty, Mechanical that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02255331, a study of Complications; Arthroplasty and Complications; Arthroplasty, Mechanical, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.

RECRUITING
Registry status
240 participants
Enrollment target
1
Study location

Study Summary

Patients with a total hip replacement may require early revision surgery due to an adverse local tissue reaction or bone resorption that occurs due to wear debris released from the implant. MRI provides a non-invasive biomarker for clinicians and surgeons to detect early adverse synovial reactions which may exist in the absence of clinical symptoms, thus imparting essential information for clinical management. This study will address two of the most commons causes of hip implant failure, including adverse local tissue reaction in implants not traditionally associated with adverse tissue reactions, as well as the presence of aseptic loosening and loss of implant-bone integration.

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2017-09-15
Est. Completion 2026-08

What the Registry Record Tells You About NCT02255331

The ClinicalTrials.gov registry entry for NCT02255331 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Complications; Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT02255331 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02255331 about?

NCT02255331 is a clinical study titled "Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity". Patients with a total hip replacement may require early revision surgery due to an adverse local tissue reaction or bone resorption that occurs due to wear debris released from the implant. MRI provides a non-invasive biomarker for clinicians and surgeons to detect early adverse synovial reactions w...

What is the current status of trial NCT02255331?

This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2017-09-15. Estimated completion is 2026-08.

What conditions does trial NCT02255331 study?

This clinical trial studies the following conditions: Complications; Arthroplasty, Complications; Arthroplasty, Mechanical.

Who is sponsoring clinical trial NCT02255331?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02255331 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Complications; Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.